Cited by 223Virus-based gene therapy researchRNA Interference and Gene DeliveryNeurogenetic and Muscular Disorders Research

The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index, and 1 are not checked yet.

In vivo model of adeno-associated virus vector persistence and rescue

Open access

Afione, S A, Conrad, C K, Kearns, W G, Chunduru, S, Adams, R, Reynolds, T C, Guggino, W B, Cutting, G R, Carter, B J, Flotte, T R·1996·Journal of Virology

DOI 10.1128/jvi.70.5.3235-3241.1996PMC PMC190187

Open this paper in CoChat — free account

Abstract

Gene therapy vectors based on human DNA viruses could be mobilized or rescued from individuals who are subsequently infected with the corresponding wild-type (wt) helper viruses. This phenomenon has been effectively modeled in vitro with both adenovirus (Ad) and adeno-associated virus (AAV) vectors but has not previously been studied in vivo. In the current study, we have developed an in vivo model to study the interactions of a recombinant AAV vector (AAV-CFTR) with wt AAV type 2 (AAV2) and a host range mutant Ad (Ad2HR405) for which monkey cells are permissive (D.E.Brough, S.A.Rice, S.Sell, and D.F.Klessig, J. Virol. 55:206-212, 1985). AAV-CFTR was administered to the respiratory epithelium of the nose or lung of rhesus macaques. Primary cells were harvested from the infusion site at time points up to 3 months after vector administration to confirm vector DNA persistence. Vector DNA was present in episomal form and could be rescued in vitro only by addition of wt AAV2 and Ad. In in vivo rescue studies, vector was administered before or after wt-AAV2 and Ad2HR405 infection, and the shedding of AAV-CFTR was examined. Ad2HR405 and wt-AAV2 infections were established in the nose with concomitant administration. wt-AAV2 replication occurred in the lung when virus was administered directly at a high titer to the lower respiratory tract. AAV-CFTR vector rescue was also observed in the latter setting. Although these studies were performed with small numbers of animals within each group, it appears that AAV-CFTR DNA persists in the primate respiratory tract and that this model may be useful for studies of recombinant AAV vector rescue.

Integrity signals

Registry

Crossref · 10.1128/jvi.70.5.3235-3241.1996

Cites

26 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L. D., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90213-v · Cited by 920
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 906
Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. J. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 824
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 783
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742
Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo
Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Pääkkö, P. K., Gilardi‐Hebenstreit, P., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1991) · Science · doi:10.1126/science.2017680 · Cited by 730
Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
Zabner, J., Couture, L., Gregory, R., Graham, S., Smith, A. E., & Welsh, M. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 657
Characterization of a preferred site on human chromosome 19q for integration of adeno‐associated virus DNA by non‐homologous recombination.
Kotin, R. M., Linden, R. M., & Berns, K. I. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05614.x · Cited by 513
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., & Carter, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10613 · Cited by 490

Show all 26 references

Sorted by citations

Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Gene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 913
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
Blömer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., & Gage, F. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6641-6649.1997 · Cited by 723
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
Samulski, R. J., & Muzyczka, N. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085355 · Cited by 609
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L. A., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
Herzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., Burton, M., Bellinger, D. A., Read, M. S., Brinkhous, K. M., et al. (1999) · Nature Medicine · doi:10.1038/4743 · Cited by 554
Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue
Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522
Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2
Rutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., & Hauswirth, W. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6916 · Cited by 409
Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis
Moss, R. B., Rodman, D. M., Spencer, L. T., Aitken, M. L., Zeitlin, P. L., Waltz, D. A., Milla, C. E., Brody, A. S., Clancy, J. P., Ramsey, B. W., et al. (2004) · CHEST Journal · doi:10.1378/chest.125.2.509 · Cited by 394
Adeno-associated viruses undergo substantial evolution in primates during natural infections
Gao, G., Alvira, M. R., Somanathan, S., Lü, Y., Vandenberghe, L. H., Rux, J. J., Calcedo, R., Sanmiguel, J. C., Abbas, Z., & Wilson, J. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937739100 · Cited by 323
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
Keeler, A. M., & Flotte, T. R. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015530 · Cited by 322
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors
Donsante, A., Vogler, C. A., Muzyczka, N., Crawford, J., Barker, J. E., Flotte, T. R., Campbell‐Thompson, M., Daly, T., & Sands, M. S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301541 · Cited by 320
Clinical gene therapy using recombinant adeno-associated virus vectors
Mueller, C., & Flotte, T. R. (2008) · Gene Therapy · doi:10.1038/gt.2008.68 · Cited by 312
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
Song, S., Morgan, M., Ellis, T., Poirier, A. E., Chesnut, K. A., Wang, J., Brantly, M., Muzyczka, N., Byrne, B. J., Atkinson, M. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14384 · Cited by 305
Viral vectors for gene delivery to the central nervous system
Lentz, T. B., Gray, S. J., & Samulski, R. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.014 · Cited by 295
Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle
Schnepp, B. C., Clark, K. R., Klemanski, D. L., Pacak, C. A., & Johnson, P. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.6.3495-3504.2003 · Cited by 262
Adeno-associated virus: from defective virus to effective vector
Gonçalves, M. A. F. V. (2005) · Virology Journal · doi:10.1186/1743-422x-2-43 · Cited by 285
Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome
Surosky, R. T., Urabe, M., Godwin, S. G., McQuiston, S. A., Kurtzman, G. J., OZAWA, K., & Natsoulis, G. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7951-7959.1997 · Cited by 244
Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study
Flotte, T. R., Zeitlin, P. L., Reynolds, T. C., Heald, A. E., Pedersen, P. S., Beck, S. E., Conrad, C., Brass‐Ernst, L., Humphries, M. R., Sullivan, K., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322124792 · Cited by 246
A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease
Aitken, M. L., Moss, R. B., Waltz, D. A., Dovey, M. E., Tonelli, M. R., McNamara, S., Gibson, R. L., Ramsey, B. W., Carter, B. J., & Reynolds, T. C. (2001) · Human Gene Therapy · doi:10.1089/104303401753153956 · Cited by 240
Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues
Schnepp, B. C., Jensen, R. L., Chen, C.-L., Johnson, P. R., & Clark, K. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14793-14803.2005 · Cited by 231
Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice
Snyder, R. O., Spratt, S. K., Lagarde, C., Bohl, D., Kaspar, B., Sloan, B. A., Cohen, L. K., & Danos, O. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.16-1891 · Cited by 210
Safety and Biological Efficacy of an Adeno‐Associated Virus Vector–Cystic Fibrosis Transmembrane Regulator (AAV‐CFTR) in the Cystic Fibrosis Maxillary Sinus
Wagner, J. A., Messner, A. H., Moran, M. L., Daifuku, R., Kouyama, K., Desch, J. K., Manley, S. A., Norbash, A., Conrad, C., Friborg, S., et al. (1999) · The Laryngoscope · doi:10.1097/00005537-199902000-00017 · Cited by 208
Adeno-Associated Virus Vectors in Clinical Trials
Carter, B. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.541 · Cited by 206
Recombinant AAV-mediated gene delivery to the central nervous system
Tenenbaum, L., Chtarto, A., Lehtonen, E., Velu, T. J., Brotchi, J., & Levivier, M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.506 · Cited by 213
Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous System
Xiao, X., Li, J., McCown, T. J., & Samulski, R. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6396 · Cited by 202
Concatamerization of Adeno-Associated Virus Circular Genomes Occurs through Intermolecular Recombination
Yang, J., Zhou, W., Zhang, Y., Zidon, T. M., Ritchie, T. L., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9468-9477.1999 · Cited by 201
PEG conjugation moderately protects adeno‐associated viral vectors against antibody neutralization
Lee, G. K., Maheshri, N., Kaspar, B., & Schaffer, D. V. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20562 · Cited by 169
Latent Adeno-Associated Virus Infection Elicits Humoral but Not Cell-Mediated Immune Responses in a Nonhuman Primate Model
Hernandez, Y. J., Wang, J., Kearns, W. G., Loiler, S., Poirier, A. E., & Flotte, T. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8549-8558.1999 · Cited by 169
Treatment of human disease by adeno-associated viral gene transfer
Warrington, K. H., & Herzog, R. W. (2006) · Human Genetics · doi:10.1007/s00439-006-0165-6 · Cited by 155
Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in Muscle
Clark, K. R., Sferra, T. J., & Johnson, P. R. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-659 · Cited by 153
Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Tenenbaum, L., Lehtonen, E., & Monahan, P. E. (2003) · Current Gene Therapy · doi:10.2174/1566523034578131 · Cited by 146
Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.
Lau, D., McGee, L. H., Zhou, S., Rendahl, K. G., Manning, W. C., Escobedo, J. A., & Flannery, J. G. (2000) · PubMed · Cited by 150
Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome
Balagué, C., Kalla, M., & Zhang, W. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3299-3306.1997 · Cited by 147
Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha 1-Antitrypsin (rAAV2-CB-hAAT) Gene Vector to AAT-Deficient Adults
Flotte, T. R., Brantly, M., Spencer, L. T., Byrne, B. J., Spencer, C. T., Baker, D. J., & Humphries, M. R. (2004) · Human Gene Therapy · doi:10.1089/10430340460732490 · Cited by 145
Recombinant Adeno-Associated Virus Expressing Human Papillomavirus Type 16 E7 Peptide DNA Fused with Heat Shock Protein DNA as a Potential Vaccine for Cervical Cancer
Liu, D.-W., Tsao, Y., Kung, J. T., Ding, Y.-A., Sytwu, H., Xiao, X., & Chen, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2888-2894.2000 · Cited by 146
Transient Immunosuppression Allows Transgene Expression Following Readministration of Adeno-Associated Viral Vectors
Manning, W. C., Zhou, S., Bland, M. P., Escobedo, J. A., & Dwarki, V. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.4-477 · Cited by 140
Adeno-associated virus vector integration junctions
Rutledge, E. A., & Russell, D. W. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8429-8436.1997 · Cited by 135
Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward
Cooney, A. L., McCray, P. B., & Sinn, P. L. (2018) · Genes · doi:10.3390/genes9110538 · Cited by 138
Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production
Allen, J. M., Debelak, D. J., Reynolds, T. C., & Miller, A. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6816-6822.1997 · Cited by 121
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
Fong, S., Yates, B., Sihn, C., Mattis, A. N., Mitchell, N., Liu, S., Russell, C. B., Kim, B. B., Lawal, A., Rangarajan, S., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01751-0 · Cited by 125
Immediate and Long-Term Safety of Recombinant Adeno-associated Virus Injection into the Nonhuman Primate Muscle
Favre, D., Provost, N., Blouin, V., Blancho, G., Chérel, Y., Salvetti, A., & Moullier, P. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0494 · Cited by 122
Gene therapy: The first two decades and the current state‐of‐the‐art
Flotte, T. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21173 · Cited by 117
Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap
Conway, J. E., Zolotukhin, S., Muzyczka, N., Hayward, G. S., & Byrne, B. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8780-8789.1997 · Cited by 115
AAV: An Overview of Unanswered Questions
Berns, K. I., & Muzyczka, N. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.048 · Cited by 111
Gene Therapy in Cystic Fibrosis
Flotte, T. R., & Laube, B. L. (2001) · CHEST Journal · doi:10.1378/chest.120.3_suppl.124s · Cited by 110
Repeated Delivery of Adeno-Associated Virus Vectors to the Rabbit Airway
Beck, S. E., Jones, L. A., Chesnut, K. A., Walsh, S. M., Reynolds, T. C., Carter, B. J., Askin, F. B., Flotte, T. R., & Guggino, W. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9446-9455.1999 · Cited by 109
Adeno-associated virus-mediated gene delivery
Snyder, R. O. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199905/06)1:3 · Cited by 106
Adeno‐associated virus vectors and hematology
Russell, D. W., & Kay, M. A. (1999) · Blood · doi:10.1182/blood.v94.3.864.415k34_864_874 · Cited by 104
Disease-Inducible Transgene Expression from a Recombinant Adeno-Associated Virus Vector in a Rat Arthritis Model
Pan, R., Xiao, X., Chen, S., Li, J., Lin, L., Wang, H.-J., & Tsao, Y. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3410-3417.1999 · Cited by 104
Persistent expression of canine factor IX in hemophilia B canines
Chao, H., Samulski, R. J., Bellinger, D. A., Monahan, P. E., Nichols, T. C., & Walsh, C. E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301024 · Cited by 102
A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency Virus
Xin, K.-Q., Urabe, M., Yang, J., Nomiyama, K., Mizukami, H., Hamajima, K., Nomiyama, H., Saito, T., Mitsunobu, I. M. A. I., Monahan, J., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750214276 · Cited by 101
Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina
McGee Sanftner, L. H., Rendahl, K. G., Quiroz, D., Coyne, M., Ladner, M., Manning, W. C., & Flannery, J. G. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0308 · Cited by 94
Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials With Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy
Ertl, H. C. J., & High, K. A. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.172 · Cited by 94
DNA-dependent PK inhibits adeno-associated virus DNA integration
Song, S., Lu, Y., Choi, Y., Han, Y., Tang, Q., Zhao, G., Berns, K. I., & Flotte, T. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307833100 · Cited by 95
Formation of Adeno-Associated Virus Circular Genomes Is Differentially Regulated by Adenovirus E4 ORF6 and E2a Gene Expression
Duan, D., Sharma, P., Dudus, L., Zhang, Y., Şanlıoğlu, S., Yan, Z., Yue, Y., Ye, Y., Lester, R., Yang, J., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.161-169.1999 · Cited by 91
Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients
Virella‐Lowell, I., Poirier, A., Chesnut, K. A., Brantly, M., & Flotte, T. R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301268 · Cited by 91
Applications of gene therapy to the CNS
Blömer, U., Naldini, L., Verma, I. M., Trono, D., & Gage, F. H. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1397 · Cited by 88
Processing of recombinant AAV genomes occurs in specific nuclear structures that overlap with foci of DNA-damage-response proteins
Cervelli, T., Palacios, J. A., Zentilin, L., Mano, M., Schwartz, R. A., Weitzman, M. D., & Giacca, M. (2008) · Journal of Cell Science · doi:10.1242/jcs.003632 · Cited by 84
Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis
Jiang, Q., & Engelhardt, J. F. (1998) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200158 · Cited by 83
Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells)
Howarth, J. L., Lee, Y., & Uney, J. B. (2009) · Cell Biology and Toxicology · doi:10.1007/s10565-009-9139-5 · Cited by 85
CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration
Burnight, E. R., Giacalone, J. C., Cooke, J. A., Thompson, J. R., Bohrer, L. R., Chirco, K. R., Drack, A. V., Fingert, J. H., Worthington, K. S., Wiley, L. A., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.003 · Cited by 79
Functional Characterization of a Recombinant Adeno- Associated Virus 5-Pseudotyped Cystic Fibrosis Transmembrane Conductance Regulator Vector
Sirninger, J. R., Müller, C. R., Braag, S. A., Tang, Q., Yue, H., Detrisac, C. J., Ferkol, T. W., Guggino, W. B., & Flotte, T. R. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.832 · Cited by 69
Optimized Production of High-Titer Recombinant Adeno-Associated Virus in Roller Bottles
Liu, Y.-L., Wagner, K. A., Robinson, N., Sabatino, D. E., Margaritis, P., Xiao, W., & Herzog, R. W. (2003) · BioTechniques · doi:10.2144/03341dd07 · Cited by 67
Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector
Lai, Z., & Brady, R. O. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10137 · Cited by 67
Adeno-Associated Virus-Based Vectors in Gene Therapy
Tal, J. (2000) · Journal of Biomedical Science · doi:10.1007/bf02253246 · Cited by 67
Viral Vector–mediated and Cell-based Therapies for Treatment of Cystic Fibrosis
Flotte, T. R., Ng, P., Dylla, D. E., McCray, P. B., Wang, G., Kolls, J. K., & Hu, J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300002 · Cited by 66
Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders
Daci, R., & Flotte, T. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021050 · Cited by 74
Enhancing rAAV vector expression in the lung
Virella‐Lowell, I., Zusman, B. D., Foust, K. D., Loiler, S., Conlon, T. J., Song, S., Chesnut, K. A., Ferkol, T. W., & Flotte, T. R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.759 · Cited by 63
Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS
Stanton, A. C., Lagerborg, K. A., Tellez, L., Krunnfusz, A., King, E. M., Ye, S. H., Solomon, I. H., Tabebordbar, M., & Sabeti, P. C. (2022) · Med · doi:10.1016/j.medj.2022.11.002 · Cited by 62
Gene Therapy for Cystic Fibrosis
Mueller, C., & Flotte, T. R. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8080-3 · Cited by 60
Advancements in the design and scalable production of viral gene transfer vectors
Sharon, D. M., & Kamen, A. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26461 · Cited by 66
Evaluation of Adeno-Associated Virus-Mediated Gene Transfer into the Rat Retina by Clinical Fluorescence Photography
Rolling, F., Shen, W.-Y., Tabarias, H. A., Constable, I. J., Kanagasingam, Y., Barry, C. J., & Rakoczy, P. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018715 · Cited by 60
Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights
López-Gordo, E., Chamberlain, K., Riyad, J. M., Kohlbrenner, E., & Weber, T. (2024) · Viruses · doi:10.3390/v16030442 · Cited by 68
Dual Reporter Comparative Indexing of rAAV Pseudotyped Vectors in Chimpanzee Airway
Flotte, T. R., Fischer, A. C., Goetzmann, J. E., Mueller, C., Cebotaru, L., Yan, Z., Wang, L., Wilson, J. M., Guggino, W. B., & Engelhardt, J. F. (2009) · Molecular Therapy · doi:10.1038/mt.2009.230 · Cited by 56
Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication
Krougliak, V. A., Krougliak, N., & Eisensmith, R. C. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(2000)9999:9999 · Cited by 6
Basic Fibroblast Growth Factor Enhances Transduction, Distribution, and Axonal Transport of Adeno-Associated Virus Type 2 Vector in Rat Brain
Hadaczek, P., Mirek, H., Bringas, J., Cunningham, J., & Bankiewicz, K. S. (2004) · Human Gene Therapy · doi:10.1089/10430340460745793 · Cited by 54
Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis
Copreni, E., Penzo, M., Carrabino, S., & Conese, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302372 · Cited by 54
Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells
Handyside, B., Ismail, A. M., Zhang, L., Yates, B., Xie, L. Y., Sihn, C., Murphy, R., Bouwman, T., Kim, C. K., Angelis, R. D., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.001 · Cited by 51
Preclinical Characterization of A Recombinant Adeno-Associated Virus Type 1-Pseudotyped Vector Demonstrates Dose-Dependent Injection Site Inflammation And Dissemination of Vector Genomes to Distant Sites
Flotte, T. R., Conlon, T. J., Poirier, A. E., Campbell‐Thompson, M., & Byrne, B. J. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.113 · Cited by 49
Targeted Integration of Adeno-Associated Virus-Derived Plasmids in Transfected Human Cells
Pieroni, L., Fipaldini, C., Monciotti, A., Cimini, D., Sgura, A., Fattori, E., Epifano, O., Cortese, R., Palombo, F., & Monica, N. L. (1998) · Virology · doi:10.1006/viro.1998.9332 · Cited by 50
Recombinant adeno-associated virus vectors for gene therapy
Conlon, T. J., & Flotte, T. R. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1093 · Cited by 49
Comparative biology of rAAV transduction in ferret, pig and human airway epithelia
Liu, X., Luo, M., Guo, C., Yan, Z., Wang, Y., & Engelhardt, J. F. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303014 · Cited by 47
Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer
Malik, A. K., Monahan, P. E., Allen, D. L., Chen, B.-G., Samulski, R. J., & Kurachi, K. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3555-3565.2000 · Cited by 48
Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques
Fischer, A. C., Beck, S. E., Smith, C. I., Laube, B. L., Askin, F. B., Guggino, S. E., Adams, R. J., Flotte, T. R., & Guggino, W. B. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.015 · Cited by 46
Adeno-Associated Virus-Based Gene Therapy for Inherited Disorders
Flotte, T. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000189226.03684.fe · Cited by 47
Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors
Hollidge, B. S., Carroll, H. B., Qian, R., Fuller, M. L., Giles, A. R., Mercer, A. C., Danos, O., Liu, Y., Bruder, J. T., & Smith, J. B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1051559 · Cited by 45
Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease
Byrne, B. J., Smith, B. K., Mah, C. S., Lawson, L. A., Islam, S., Corti, M., Martin, D., Dobija, N., Irwin, M. V., Conlon, T. J., et al. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2014.2514 · Cited by 45
Size does matter: overcoming the adeno-associated virus packaging limit
Flotte, T. R. (2000) · Respiratory Research · doi:10.1186/rr6 · Cited by 45
A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells
Freundlieb, S., Schirra‐Müller, C., & Bujard, H. (1999) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(199901/02)1:1 · Cited by 262
Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors
Braun‐Falco, M., Doenecke, A., Smola, H., & Hallek, M. J. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300815 · Cited by 45
Structural and functional heterogeneity of integrated recombinant AAV genomes
Duan, D., Fisher, K. J., Burda, J. F., & Engelhardt, J. F. (1997) · Virus Research · doi:10.1016/s0168-1702(96)01425-6 · Cited by 45
Gene Therapeutic Strategies for Neuroprotection: Implications for Parkinson's Disease
Bowers, W. J., Howard, D. F., & Federoff, H. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6389 · Cited by 44
A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs
Cooney, A. L., Thornell, I. M., Singh, B. K., Shah, V. S., Stoltz, D. A., McCray, P. B., Zabner, J., & Sinn, P. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0006oc · Cited by 42
In vivo gene delivery to articular chondrocytes mediated by an adeno‐associated virus vector
Ulrich‐Vinther, M., Duch, M., Søballé, K., O’Keefe, R. J., Schwarz, E., & Pedersen, F. S. (2004) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2003.12.003 · Cited by 42
Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease
Heller, G., Marshall, M. S., Issa, Y., Marshall, J. N., Nguyen, D. A., Rue, E. A., Pathmasiri, K. C., Domowicz, M. S., van Breemen, R. B., Tai, L. M., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.026 · Cited by 39
Progress in Direct Striatal Delivery of l-Dopa via Gene Therapy for Treatment of Parkinson's Disease Using Recombinant Adeno-Associated Viral Vectors
Mandel, R. J., Rendahl, K. G., Snyder, R. O., & Leff, S. E. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7159 · Cited by 38
Cartilage Regeneration by Gene Therapy
Gelse, K., von der Mark, K., & Schneider, H. (2003) · Current Gene Therapy · doi:10.2174/1566523034578276 · Cited by 38

Authors: Afione, S. A., Conrad, C. K., Kearns, W. G., Chunduru, S., Adams, R., Reynolds, T. C., Guggino, W. B., Cutting, G. R., Carter, B. J., & Flotte, T. R.
Affiliations: Johns Hopkins University (US)
ORCID: Conrad, C K
Kearns, W G
Adams, R
Reynolds, T C
Cutting, G R
Flotte, T R
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 1996-05
Volume: 70
Issue: 5
Pages: 3235-3241
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.70.5.3235-3241.1996
PMC: PMC190187
OpenAlex: W2159706578
Cited by: 223
References: 26
Citations by year: 2026: 1 · 2025: 2 · 2024: 4 · 2022: 8 · 2021: 4 · 2020: 10 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 6 · 2012: 4
FWCI: 11.20
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (P01HL051811, HL 51811.)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Keywords: adeno-associated virus vectors, vector persistence, AAV2, adenovirus type 2, rhesus monkeys, respiratory tract, gene therapy vectors
MeSH terms: Dependovirus, Adenoviridae, Animals, Base Sequence, Bronchi, Bronchoalveolar Lavage Fluid, Cell Line, Cells, Cultured, Epithelial Cells, Epithelium, Genetic Vectors, HeLa Cells, Helper Viruses, Humans, Macaca mulatta, Molecular Sequence Data, Recombination, Genetic, Genetic Therapy, Polymerase Chain Reaction, Mutagenesis, Virus Shedding, In Situ Hybridization, Fluorescence, DNA Primers, Cystic Fibrosis Transmembrane Conductance Regulator

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

In vivo model of adeno-associated virus vector persistence and rescue

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks